Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hunt

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
Infection Control and Hospital Epidemiology|February 3, 2016
Evaluation of a Novel Intervention to Reduce Unnecessary Urine Cultures in Intensive Care Units at a Tertiary Care Hospital in Maryland, 2011-2014Lauren Epstein, Jonathan R Edwards, Alison Laufer Halpin, et al.
JAMA|June 16, 2005
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trialsShamir R Mehta, Christopher P Cannon, Keith A A Fox, et al.
Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.
Circulation. Cardiovascular Quality and Outcomes|July 18, 2023
Relationship Between In-Hospital Adverse Events and Hospital Performance on 30-Day All-cause Mortality and Readmission for Patients With Heart FailureYun Wang, Noel Eldridge, Mark L Metersky, et al.
Journal of the American College of Cardiology|October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)Harvey D White, Andrew Tonkin, John Simes, et al.
Journal of the American College of Cardiology|May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?Harvey D White, Andrew Tonkin, John Simes, et al.
International Journal of Cardiology|July 22, 2017
Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction modelAndrea Driscoll, Elizabeth H Barnes, Stefan Blankenberg, et al.
Anesthesia and Analgesia|December 20, 2008
A novel process for introducing a new intraoperative program: a multidisciplinary paradigm for mitigating hazards and improving patient safetyJose M Rodriguez-Paz, Lynette J Mark, Kurt R Herzer, et al.
Nature Communications|September 4, 2024
Hydrogen storage with gravel and pipes in lakes and reservoirsJulian David Hunt, Andreas Nascimento, Oldrich Joel Romero, et al.
Journal of Epidemiology and Community Health|October 15, 2009
Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factorsAlison Beauchamp, Anna Peeters, Rory Wolfe, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Infection Control and Hospital Epidemiology|February 3, 2016
Evaluation of a Novel Intervention to Reduce Unnecessary Urine Cultures in Intensive Care Units at a Tertiary Care Hospital in Maryland, 2011-2014Lauren Epstein, Jonathan R Edwards, Alison Laufer Halpin, et al.
JAMA|June 16, 2005
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trialsShamir R Mehta, Christopher P Cannon, Keith A A Fox, et al.
Circulation|March 13, 2002
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?R John Simes, Ian C Marschner, David Hunt, et al.
Circulation. Cardiovascular Quality and Outcomes|July 18, 2023
Relationship Between In-Hospital Adverse Events and Hospital Performance on 30-Day All-cause Mortality and Readmission for Patients With Heart FailureYun Wang, Noel Eldridge, Mark L Metersky, et al.
Journal of the American College of Cardiology|October 22, 2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease)Harvey D White, Andrew Tonkin, John Simes, et al.
Journal of the American College of Cardiology|May 6, 2014
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?Harvey D White, Andrew Tonkin, John Simes, et al.
International Journal of Cardiology|July 22, 2017
Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction modelAndrea Driscoll, Elizabeth H Barnes, Stefan Blankenberg, et al.
Anesthesia and Analgesia|December 20, 2008
A novel process for introducing a new intraoperative program: a multidisciplinary paradigm for mitigating hazards and improving patient safetyJose M Rodriguez-Paz, Lynette J Mark, Kurt R Herzer, et al.
Nature Communications|September 4, 2024
Hydrogen storage with gravel and pipes in lakes and reservoirsJulian David Hunt, Andreas Nascimento, Oldrich Joel Romero, et al.
Journal of Epidemiology and Community Health|October 15, 2009
Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factorsAlison Beauchamp, Anna Peeters, Rory Wolfe, et al.
Pageof 19